BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.550
+0.100 (6.90%)
At close: Dec 20, 2024, 4:00 PM
1.480
-0.070 (-4.52%)
After-hours: Dec 20, 2024, 4:50 PM EST
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2023. The number of employees increased by 1 or 10.00% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
10.00%
Revenue / Employee
$34,273
Profits / Employee
-$877,021
Market Cap
10.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BiomX | 71 |
Eyenovia | 57 |
Jaguar Health | 49 |
Apollomics | 45 |
Aptose Biosciences | 36 |
Cellectar Biosciences | 20 |
Can-Fite BioPharma | 8 |
Ensysce Biosciences | 7 |
BRTX News
- 16 days ago - BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program - GlobeNewsWire
- 5 weeks ago - BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health - GlobeNewsWire
- 2 months ago - BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire
- 3 months ago - BioRestorative Therapies' IFATS 2024 Presentation to Feature ThermoStem® Platform's Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs - GlobeNewsWire
- 4 months ago - BioRestorative Therapies, Inc. (BRTX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - BioRestorative Therapies' Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine - GlobeNewsWire
- 6 months ago - BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program - GlobeNewsWire